J. B. Chemicals & Pharmaceuticals Limited Stock NSE India S.E.
Equities
JBCHEPHARM
INE572A01036
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,863 INR | +2.10% | +3.62% | +14.66% |
Sales 2024 * | 35.01B 420M | Sales 2025 * | 40.58B 487M | Capitalization | 283B 3.4B |
---|---|---|---|---|---|
Net income 2024 * | 5.66B 67.98M | Net income 2025 * | 7.11B 85.41M | EV / Sales 2024 * | 8.13 x |
Net Debt 2024 * | 1.68B 20.22M | Net cash position 2025 * | 4.42B 53.07M | EV / Sales 2025 * | 6.87 x |
P/E ratio 2024 * |
46.9
x | P/E ratio 2025 * |
37.5
x | Employees | 5,095 |
Yield 2024 * |
0.67% | Yield 2025 * |
0.72% | Free-Float | 45.82% |
Latest transcript on J. B. Chemicals & Pharmaceuticals Limited
1 day | +2.10% | ||
1 week | +3.62% | ||
Current month | +12.87% | ||
1 month | +15.27% | ||
3 months | +9.87% | ||
6 months | +43.57% | ||
Current year | +14.66% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 20-10-04 | |
Bharat Dhanani
COO | Chief Operating Officer | - | - |
Sujay Rajhans
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 59 | 20-08-30 | |
Akshay Tanna
BRD | Director/Board Member | 40 | Nov. 06 |
Gaurav Trehan
BRD | Director/Board Member | 48 | 21-02-09 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 1,863 | +2.10% | 191 404 |
24-04-24 | 1,825 | +2.26% | 133,182 |
24-04-23 | 1,784 | -0.21% | 113,740 |
24-04-22 | 1,788 | +0.47% | 212,672 |
24-04-19 | 1,780 | -1.01% | 202,911 |
Delayed Quote NSE India S.E., April 25, 2024 at 06:10 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.61% | 660B | |
+22.95% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+12.60% | 219B | |
-9.82% | 196B | |
+6.52% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- JBCHEPHARM Stock
- JBCHEPHARM Stock